Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cellebrite DICLBT +2.92%81 Equity-to-Asset is 0.54 as of Jun. 2026, which is 200% above its 10-year median of 0.18. GuruFocus rates CLBT with a GF Score™ of 81/100 and a GF Value™ of $16.32 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 2,895 Software companies, Cellebrite DI ranks worse than 51.54% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cellebrite DI's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $538.1 Mil. Cellebrite DI's Total Assets for the quarter that ended in Jun. 2026 was $994.3 Mil.
Therefore, Cellebrite DI's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.54.
The historical rank and industry rank for Cellebrite DI's Equity-to-Asset or its related term are showing as below:
CLBT'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.41 Med: 0.18 Max: 0.54
Current: 0.54
During the past 7 years, the highest Equity to Asset Ratio of Cellebrite DI was 0.54. The lowest was -0.41. And the median was 0.18.
CLBT's Equity-to-Asset is ranked worse than 51.54% of 2895
companies
in the Software industry
Industry Median: 0.55
vs CLBT: 0.54
Cellebrite DI (NAS:CLBT) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Cellebrite DI Equity-to-Asset Related Terms
Cellebrite DI Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Cellebrite DI's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CLBT vs TENB, PAY, BLSH: Equity-to-Asset Comparison
For the Software - Infrastructure subindustry, Cellebrite DI's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cellebrite DI Equity-to-Asset vs Software Industry
For the Software industry and Technology sector, Cellebrite DI's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Cellebrite DI's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Cellebrite DI's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cellebrite DI (CLBT) has a Equity-to-Asset of 0.54 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Cellebrite DI and its competitors. This is 200% above median its historical median of 0.18. According to the industry distribution chart, Cellebrite DI ranks #1492 out of 2895 companies in the Software industry, placing it in the top 51.5%.
Is Cellebrite DI's Equity-to-Asset too high?
Cellebrite DI's current Equity-to-Asset of 0.54 is 200% above median its 10-year median of 0.18. The Software industry median Equity-to-Asset is 0.55. Cellebrite DI's value of 0.54 is 1.8% below this industry median. Based on the distribution chart, Cellebrite DI ranks #1492 out of 2895 companies in the Software industry, which is below the industry midpoint. Overall, Cellebrite DI has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cellebrite DI's Equity-to-Asset compare to TENB and PAY?
According to the Software industry distribution chart, Cellebrite DI ranks #1492 out of 2895 companies for Equity-to-Asset. This places Cellebrite DI in the lower half of its industry. The industry median Equity-to-Asset is 0.55. Cellebrite DI's value of 0.54 is 1.8% below this benchmark. While the company's 10-year median is 0.18 vs. the industry median of 0.55, Cellebrite DI has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Software company?
The median Equity-to-Asset among Software companies is 0.55, based on 2,895 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cellebrite DI's current Equity-to-Asset of 0.54 is 1.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Cellebrite DI and its competitors. For the Software industry, the median Equity-to-Asset is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cellebrite DI's current Equity-to-Asset is 0.54, which is 200% above median its own 10-year median of 0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellebrite DI stock overvalued right now?
Based on GuruFocus' analysis, Cellebrite DI (CLBT) is currently considered Modestly Undervalued. The stock's GF Value™ is $16.32, compared to a current price of $11.63 — trading 28.7% below its estimated fair value. The current Equity-to-Asset is 0.54, which is 200% above median its 10-year median of 0.18 and 1.8% below the Software industry median of 0.55. Cellebrite DI's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Cellebrite DI (CLBT), the current Equity-to-Asset is 0.54 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cellebrite DI (CLBT) Overvalued in 2026?
Based on GuruFocus' analysis, Cellebrite DI stock appears to be undervalued.
The current stock price of $11.63 is trading 28.7% below its estimated GF Value™ of $16.32.
GuruFocus considers Cellebrite DI to be Modestly Undervalued.
Key valuation signals for CLBT:
Equity-to-Asset: 0.54 (200% above median its 10-year median of 0.18)
GF Value™: $16.32 vs. price of $11.63 (28.7% below fair value)
Industry Position: 1.8% below the Software median (#1492 of 2895)
No single metric tells the full story. See the CLBT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
81GF Score
Get the complete analysis for CLBT
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLBT has been successfully added to your 
